Introduction: This study aimed to clarify the correlation between the number of AMs and prognosis and to examine the gene expression of AMs in lung squamous cell carcinoma (SqCC).Methods: We reviewed 124 stage I lung SqCC cases in our hospital and 139 stage I lung SqCC cases in The Cancer Genome Atlas (TCGA) cohort in this study. We counted the number of AMs in the peritumoral lung eld (P-AMs), and in the lung eld distant from the tumor (D-AMs). Moreover, we performed a novel ex vivo bronchoalveolar lavage uid (BALF) analysis to select AMs from surgically resected lung SqCC cases and examined the expression of IL10, CCL2, IL6, TGFβ, and TNFα (n=3).Results: Patients with high P-AMs had signi cantly shorter overall survival (OS) (p<0.01); however, patients with high D-AMs did not have signi cantly shorter OS. Moreover, in TCGA cohort, patients with high P-AMs had a signi cantly shorter OS (p<0.01). In multivariate analysis, a higher number of P-AMs was an independent poor prognostic factor (p=0.02). Ex vivoBALF analysis revealed that AMs collected from the tumor vicinity showed higher expression of IL10 and CCL2 than AMs from distant lung elds in all 3 cases (IL-10: 2.2, 3.0, and 10.0-fold; CCL-2: 3.0, 3.1, and 3.2-fold). Moreover, addition of recombinant CCL2 signi cantly increased the proliferation of RERF-LC-AI, a lung SqCC cell line.
Conclusion:The current results indicated the prognostic impact of the number of peritumoral AMs and suggested the importance of peritumoral tumor microenvironment in lung SqCC progression.